Citation Impact
Citing Papers
Ferroptosis: past, present and future
2020 Standout
The genetics, if any, of infantile autism and childhood schizophrenia
1976
Amyotrophic lateral sclerosis, Parkinson's disease, and the amyotrophic lateral sclerosis-Parkinsonism-dementia complex on Guam: a review and summary of attempts to demonstrate infection as the aetiology
1972 StandoutNobel
The neural basis of drug craving: An incentive-sensitization theory of addiction
1993 Standout
Outcomes for Implementation Research: Conceptual Distinctions, Measurement Challenges, and Research Agenda
2010 Standout
Nicotinic acetylcholine receptors as targets for antidepressants
2002
Imaging Biomarkers for the Diagnosis and Prognosis of Neurodegenerative Diseases. The Example of Amyotrophic Lateral Sclerosis
2018
Iron Accumulation in Deep Cortical Layers Accounts for MRI Signal Abnormalities in ALS: Correlating 7 Tesla MRI and Pathology
2012
Chlorpromazine versus placebo for schizophrenia
2007
Niemann-Pick disease type C
2010 Standout
Efficacy of Transcranial Magnetic Stimulation Targets for Depression Is Related to Intrinsic Functional Connectivity with the Subgenual Cingulate
2012 Standout
Measuring and manipulating brain connectivity with resting state functional connectivity magnetic resonance imaging (fcMRI) and transcranial magnetic stimulation (TMS)
2012
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
2017 Standout
White matter alterations differ in primary lateral sclerosis and amyotrophic lateral sclerosis
2011
Statewide adoption and initial implementation of contingency management for substance-abusing adolescents.
2008
Positron Emission Tomographic Analysis of Central D1 and D2 Dopamine Receptor Occupancy in Patients Treated With Classical Neuroleptics and Clozapine
1992 Standout
Efflux-mediated heavy metal resistance in prokaryotes
2003 Standout
Amyotrophic lateral sclerosis
2011 Standout
Widespread cerebral haemodynamics disturbances occur early in amyotrophic lateral sclerosis
2012
Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans
1994 Standout
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
2018 Standout
Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia
2000 StandoutNobel
Environmental Epidemiology of Essential Tremor
2008
Decoding ALS: from genes to mechanism
2016 StandoutNature
Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research
2009 Standout
Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
2002 Standout
How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor
2010 Standout
Transcranial Magnetic Stimulation of Left Temporoparietal Cortex and Medication-Resistant Auditory Hallucinations
2003 Standout
Autism: Towards an Integration of Clinical, Genetic, Neuropsychological, and Neurobiological Perspectives
1996 Standout
Treatment of patients with essential tremor
2011
White matter integrity, fiber count, and other fallacies: The do's and don'ts of diffusion MRI
2012 Standout
The emerging neuropathology of essential tremor
2007
Amyotrophic Lateral Sclerosis
2010
Major Depressive Disorder
2008 Standout
The role of iron in brain ageing and neurodegenerative disorders
2014 Standout
Long-term motor cortex stimulation for amyotrophic lateral sclerosis
2009
Electrodiagnostic criteria for diagnosis of ALS
2008
Autism as a strongly genetic disorder: evidence from a British twin study
1995 Standout
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
Autism: Review of neurochemical investigation
1990
A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics
1975
Chlorpromazine versus placebo for schizophrenia
2014
A behavioural study of the changes in the central nervous system of mice after subchronic treatment with the selective dopamine autoreceptor agonist 3-PPP (dl-3-[3-hydroxyphenyl]-N-n-propylpiperidine)
1982 StandoutNobel
ALS motor phenotype heterogeneity, focality, and spread
2009
Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms
1984
A Rating Scale for Mania: Reliability, Validity and Sensitivity
1978 Standout
Infantile Autism Reviewed: A Decade of Research
1981
The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia
1987 Standout
Neurobiological vulnerability to low-dose amphetamine psychosis
1978
A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis
2008
CNS stimulants as tools in the study of schizophrenia
1984
Psychoactive Drugs in Mania
1975
Psychopathology Induced by “Speed Drugs”
1981
Haloperidol versus chlorpromazine for schizophrenia
2008
Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex
1997 Standout
National Service Framework for Mental Health
2000 Standout
Behavioral treatment and normal educational and intellectual functioning in young autistic children.
1987 Standout
A faulty negative feedback control underlies the schizophrenic syndrome?
1991 StandoutNobel
Frequency Dependence of Signal Power and Spatial Reach of the Local Field Potential
2013 Standout
Following several days of continuous administration d-amphetamine acquires hallucinogenlike properties
1980
Dose equivalence of the anti-psychotic drugs
1974
Business Artificial Intelligence
2021 Standout
Amphetamine-Induced Dopaminergic Hypersensitivity in Guinea Pigs
1975
Recent advances in the phencyclidine model of schizophrenia
1991 Standout
Instrumented Measurement of Patellar Mobility
1995
The central stimulatory action of inhibitors of the dopamine uptake
1979
Amphetamine psychosis: Behavioral and biochemical aspects
1974
Epidemiology and Natural History of Acute Patellar Dislocation
2004 Standout
Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis
1986 Standout
Assessment of Social Adjustment by Patient Self-Report
1976 Standout
Industry sponsorship and research outcome
2017 Standout
Catecholamines in the Brain as Mediators of Amphetamine Psychosis
1972
(+)-AJ 76 and (+)-UH 232: Central stimulants acting as preferential dopamine autoreceptor antagonists
1986 StandoutNobel
Comparative Doses and Costs of Antipsychotic Medication
1976
Autismo e doenças invasivas de desenvolvimento
2004 Standout
Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis
1986 Standout
Works of A Floyd being referenced
Non-correlation of preclinical-clinical evaluation of a prosposed anti-depressant 4-phenyl-bicyclo(2,2,2)octan-1-amine hydrochloride monohydrate (EXP 561).
1968
The Clinical Symptomatology of Amphetamine Psychosis and its Relationship to Amphetamine Levels in Urine
1969
Direct Care Workers in the National Drug Abuse Treatment Clinical Trials Network: Characteristics, Opinions, and Beliefs
2007
Intention tremor of the head in patients with essential tremor
2006
Kinematic analysis of motor dysfunction in Niemann-Pick type C
2007
Spiral analysis in Niemann‐Pick disease type C
2009
Relative efficacy of butaperazine and chlorpromazine in acute schizophrenia.
1970
Recurrent dislocation of the patella. Histochemical and electromyographic evidence of primary muscle pathology
1987
A controlled evaluation of haloperidol, chlorpromazine, and sodium amobarbital: intramuscular short-term use in acute psychotic patients.
1969
Transcranial magnetic stimulation in ALS
2009
Study of molindone in disturbed preschool children.
1971
Schizophrenic children treated with methysergide (sansert).
1969
Acute responses of schizophrenic children to a sedative and a "stimulating" neuroleptic: a pharmacologic yardstick.
1972
Comparison of trifluperidol, trifluoperazine and chlorpromazine in preschool schizophrenic children: the value of less sedative antipsychotic agents.
1969
Quantitative objective markers for upper and lower motor neuron dysfunction in ALS
2007